Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Yatai Yongantang Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of the Jilin Yatai Group. The company specializes in the research, development, and large-scale manufacturing of traditional Chinese medicines (TCM), chemical drugs, and health supplements. Its product portfolio includes well-known formulations for cardiovascular health, respiratory ailments, and digestive disorders, leveraging the historic Yongantang brand which dates back to 1429. Operating out of Jilin Province, the company maintains modern GMP-certified facilities and integrates traditional herbal wisdom with contemporary pharmaceutical technology. The firm is a key player in the regional healthcare sector, focusing on high-quality production and brand heritage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Yatai Yongantang Pharmaceutical.